Zensun   Report issue

For profit Phase 2 Phase 3
Founded: Shanghai China (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2010
NCT01131637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Zensun Sci. & Tech. Co., Ltd. | Zensun USA Inc.